LAWSUITS NEWS & LEGAL INFORMATION
Drugs/Medical Legal News Articles & Interviews
Depo-Provera Lawsuit November 2024 Update
November 19, 2024. By LAS Staff Writer.
Read [ Depo-Provera Lawsuit November 2024 Update ]
Valsartan Lawsuit October 2024 Update
November 7, 2024. By LAS Staff Writer.
Read [ Valsartan Lawsuit October 2024 Update ]
A Setback for Suboxone Film Plaintiffs: Northern District of Ohio's Dismissal Decision
November 6, 2024. By Anne Wallace.
Cleveland, OH On September 10, 2024, the Northern District of Ohio dismissed claims against Indivior PLC and two Reckitt Benckiser entities in Suboxone (Buprenorphine/Naloxone) Film Products Liability Litigation in the multidistrict litigation centralized in the Northern District of Ohio. The court’s decision is a significant setback for individuals who suffered serious Suboxone side effects and dental damage from using the sublingual film form of the drug. They allege that Indivior and other defendants failed to adequately warn about the potential for dental erosion and decay associated with the film's acidic properties.
Read [ A Setback for Suboxone Film Plaintiffs: Northern District of Ohio's Dismissal Decision ]
Sen. Warren Raises the Alarm over Catalent/Novo Nordisk Merger
November 1, 2024. By Anne Wallace.
Washington, DC On October 10, U.S. Senator Elizabeth Warren sent a letter to Federal Trade Commission (FTC) Chair Lina Khan, urging the FTC to closely review a proposed merger between Novo Nordisk and Catalent. Catalent is one of the very few suppliers that provide specialized development and manufacturing services to GLP-1 manufacturers. The letter urges the FTC to block the deal if it could hurt Americans by limiting competition and raising the price of life-saving medicine. Not coincidentally, killing competition might also limit the development of drugs without the dangerous side effects of Ozempic.
Read [ Sen. Warren Raises the Alarm over Catalent/Novo Nordisk Merger ]
Zantac Maker Agrees to $2.2 Billion Settlement
October 24, 2024. By Jane Mundy.
Santa Clara, CA The drug maker GSK agreed a few weeks ago to pay up to $2.2 billion to resolve Zantac lawsuits. The blockbuster heartburn drug, which was sold over-the-counter, was removed from the market in 2020 after the FDA ordered all ranitidine (the generic name) products withdrawn, citing unacceptable levels of the chemical N-nitroso dimethylamine (NDMA), a probable human carcinogen.
Read [ Zantac Maker Agrees to $2.2 Billion Settlement ]
Ozempic and Addiction: A Potential Game-Changer?
October 23, 2024. By Anne Wallace.
Washington, DC Ozempic, a semaglutide, is a medication primarily used to treat type 2 diabetes. It works by mimicking the effects of a hormone called glucagon-like peptide-1 (GLP-1), which helps regulate blood sugar levels. However, recent studies have revealed a surprising potential benefit: addiction reduction, specifically with reference to alcohol and opioid abuse.
Read [ Ozempic and Addiction: A Potential Game-Changer? ]
Suboxone Tooth Decay MDL – Status Update
October 21, 2024. By Anne Wallace.
Cleveland, OH In recent years, Suboxone, a critical medication used to treat opioid addiction, has come under fire for its unintended side effects—specifically, severe tooth decay. While the drug has helped millions overcome opioid dependence, patients across the country have filed dangerous drug lawsuits claiming that Suboxone caused serious dental problems, leading to painful and costly procedures as well as social isolation for some individuals. These claims have been consolidated in an ongoing multidistrict litigation (MDL) in the Northern District of Ohio, where patients are suing the manufacturers of Suboxone for failing to warn about the risk of tooth decay.
Read [ Suboxone Tooth Decay MDL – Status Update ]
Agreement to Settle nearly 38,000 Bard Hernia Mesh Lawsuits
October 18, 2024. By Jane Mundy.
Columbus, OH Becton, Dickinson and Company (BD), the parent company of BARD, has agreed to settle about 38,000 hernia mesh lawsuits. Reports indicate that the total payouts could exceed $1 Billion. The mesh lawsuits, some of which go back almost 20 years, allege that Bard designed defective mesh products, failed to adequately test them, and didn’t properly warn users about potential risks.
Read [ Agreement to Settle nearly 38,000 Bard Hernia Mesh Lawsuits ]
Tips for Maximizing Your Compensation in a Malpractice Case
October 11, 2024. By LAS Staff Writer.
Santa Clara, CA Medical malpractice happens when a healthcare expert, via omission or negligent act, injures or causes harm to patients. If you suffer any harm or are injured because of a healthcare professional’s negligence, you’re entitled to compensation. However, your settlement amount primarily depends on how you handle your medical malpractice lawsuit. Discussed below are four tips for maximizing your compensation in a malpractice case.
Read [ Tips for Maximizing Your Compensation in a Malpractice Case ]
Exactech Knee Lawsuit Trial Update
September 26, 2024. By Jane Mundy.
Santa Clara, CA The first Exactech knee bellwether trials in multi-district litigation are slated for July and September 2025. At least 1,670 Exactech lawsuits are involved, blaming a packaging problem that caused hip, knee, shoulder and ankle implants to degrade and fail long before their time. Some patients required replacement surgery within a few years of receiving the implant.
Read [ Exactech Knee Lawsuit Trial Update ]
- Suboxone Tooth Decay Lawsuits Reflect Only Part of Harm By Anne Wallace (Sep-23-24)
- Ozempic Linked to Serious Pain in the Pocketbook By Anne Wallace (Sep-19-24)
- State AGs Nail $86 Million Suboxone Settlement By Anne Wallace (Aug-21-24)
- Popular Diabetes/Weight Loss Drugs Linked to Rare Form of Blindness By Anne Wallace (Aug-15-24)
- Fourth Bellwether Trial Scheduled in Exactech MDL By Anne Wallace (Aug-13-24)
- Baby Formula Lawsuits Rising By Jane Mundy (Aug-12-24)
- Suboxone Lawsuit Update By Jane Mundy (Aug-8-24)
- Exactech Recalls Shoulder Devices By Jane Mundy (Aug-5-24)
- Reasons to Quit Ozempic By Jane Mundy (Jul-25-24)
- $9.5 Million Army Hospital Medical Malpractice Settlement By Anne Wallace (Jul-12-24)
- Thousands More Suboxone Lawsuits By Jane Mundy (Jun-30-24)
- More Ozempic Side Effects—from Sagging Breasts to Compulsive Behavior By Jane Mundy (Jun-14-24)
- Reading Hospital Settles $32.5M Birth Injury Lawsuit By Jane Mundy (May-24-24)
- Suboxone Statute of Limitations By Jane Mundy (May-16-24)
- Ozempic and Wegovy Linked to Aspiration Pneumonia By Jane Mundy (May-15-24)
- Philips Settles Respirator Case for $1.1 Billion By Jane Mundy (May-9-24)
- Surgeons Warned to Stop Using Synovo Total Hip Implants By Anne Wallace (Apr-24-24)
- Bard PowerPort Bellwether Trial Process on Time By Jane Mundy (Apr-19-24)
- Ozempic Babies, Another Side Effect By Jane Mundy (Apr-17-24)
- Exactech Defective Hip Implant MDL Takes Shape By Anne Wallace (Mar-25-24)
- Ozempic MDL and Semaglutide Update By Jane Mundy (Mar-15-24)
- Lawsuits Allege Ozempic Caused Gastroparesis; Do You Have A Claim? By Jane Mundy (Mar-8-24)
- Chicago Hospital Settles Class Action for $55M By Jane Mundy (Feb-22-24)
- Suboxone maker Indivior in Trouble with the Law Again By Jane Mundy (Feb-16-24)
- New York MDL Consolidates Growing Number of Exactech Defective Hip Implant Lawsuits By Anne Wallace (Feb-9-24)
- Weight Loss Drugmakers Face Stomach Paralysis Lawsuits By Jane Mundy (Jan-27-24)
- Problems with Philips CPAP Replacement Machines By Jane Mundy (Jan-10-24)
- Navigating Legal Challenges Faced by People With Cerebral Palsy By LAS Staff Writer (Dec-18-23)
- Exactech Hip Recall Attorney Weighs In By Jane Mundy (Nov-30-23)
- Bard to Pay $500,000 in Third Bellwether Trial By Jane Mundy (Nov-25-23)
- Attorney Discusses Bard Power Port Failures and Lawsuits By Jane Mundy (Nov-2-23)
- Exactech Implants Worn Out Before Their Time By Jane Mundy (Oct-31-23)
- Philips Cuts Deal with Owners of Recalled CPAP Machines and Lawsuit Claims FDA Fails CPAP Users By Jane Mundy (Oct-9-23)
- Experienced Birth Injury Attorneys Discuss Lawsuits and Settlements By Jane Mundy (Sep-23-23)
- New FDA Hernia Mesh Information and its Flawed 501(k) Process By Jane Mundy (Sep-6-23)
- Philips’ Objections Over CPAP Lawsuits and Another Obstacle By Jane Mundy (Aug-21-23)
- Hernia Mesh Updates: Bard Trial and FDA’s Pros and Cons By Jane Mundy (Jul-25-23)
- Plaintiff Alleges Surgical Mesh “Traumatizing” By Jane Mundy (Jun-26-23)
- CPAP Lawsuit Spike Linked to Statute of Limitations By Jane Mundy (Jun-21-23)
- Philips CPAP Recall and Test Results Update By Jane Mundy (May-24-23)